Shan Cong

643 citations
33 papers · 468 indexed · h-index 14
Topics
Cancer-related molecular mechanisms research (4 papers)RNA modifications and cancer (4 papers)Eicosanoids and Hypertension Pharmacology (3 papers)
Journals
SHILAP Revista de lepidopterologíaScientific ReportsMolecules
Partner nations
ChinaUnited States

In The Last Decade

Shan Cong

30 papers receiving 465 citations

Peers

Shan Cong
Comparison fields: 5 of 87
  • Molecular Biology 284
  • Cancer Research 100
  • Immunology 74
  • Pharmacology 60
  • Pulmonary and Respiratory Medicine 58
Replace Min Gao with:
Min Gao China
Guosheng Zhao China
Seong‐Man Kim South Korea
Peyman Kheirandish Zarandi Iran
Xiaofei Ma China
Xinru Jiang China
S. Choudhary United States
Hamid‐Reza Mohammadi‐Motlagh Iran
Wenbin Chen China
Nannan Yin China
Shan Cong relative to Min Gao China Min Gao's profile →
Citations per field
00.5×1.5×
Min Gao · 1×
Citations per year

Countries citing papers authored by Shan Cong

Since Specialization
Citations

This map shows the geographic impact of Shan Cong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shan Cong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shan Cong more than expected).

Fields of papers citing papers by Shan Cong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shan Cong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shan Cong. The network helps show where Shan Cong may publish in the future.

Co-authorship network of co-authors of Shan Cong

This figure shows the co-authorship network connecting the top 25 collaborators of Shan Cong. A scholar is included among the top collaborators of Shan Cong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shan Cong. Shan Cong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 3
4 14
5 1
6 17
7 37
8 83
9 1
10 7
11 14
12 3
13 19
14 28
15 37
16 12
17 12
18 15
19
Bovine embryonic stem cells cultured on STO feeder layer cells treated with domestic mytomycin.
1
20 18

About Shan Cong

Shan Cong is a scholar working on Cancer Research, Pharmacology and Biochemistry, having authored 33 papers that have together received 468 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (4 papers), RNA modifications and cancer (4 papers) and Eicosanoids and Hypertension Pharmacology (3 papers). The work is most often cited by research in Pharmacology (60 citations), Cancer Research (100 citations) and Molecular Biology (284 citations). Shan Cong has collaborated with scholars based in China and United States. Frequent co-authors include Chang Fu Tian, Xiaoqian Li, Bo Tan, Min Zhao, Xin Di, Dong Bai, Ranwei Li, Zhonghua Wu, Jiaying Liu and Xin Jin. Their work appears in journals such as SHILAP Revista de lepidopterología, Scientific Reports and Molecules.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026